Dose-dependent effects of strontium on bone of chronic renal failure rats

Kidney International

Volumn 63, Issue 3, 2003, Pages 927-935

  Schrooten, Iris ^b   Behets, Geert J S ^b   Cabrera, Walter E ^b   Vercauteren, Sven R ^b   Lamberts, Ludwig V ^b   Verberckmoes, Steven C ^b   Bervoets, An J ^b   Dams, Geert ^b   Goodman, William G ^b   De Broe, Marc E ^a   D'Haese, Patrick C ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Mineralization; Osteoblast function; Osteomalacia; Remnant kidney; Trace element

Indexed keywords

STRONTIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DEVELOPMENT; BONE LESION; BONE MINERALIZATION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE KIDNEY FUNCTION RELATION; DRUG BONE LEVEL; EXPERIMENTAL MODEL; HYPERPARATHYROIDISM; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOMALACIA; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RAT; SPECIES COMPARISON;

EID: 12244260745     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00809.x     Document Type: Article

References (32)

1. D'HAESE PC, SCHROOTEN I, GOODMAN WG, et al. Increased bone strontium levels in dialysis patients with osteomalacia. Kidney Int 57:1107-1114, 2000
2. D'HAESE PC, COUTTENYE M-M, LAMBERTS LV, et al: Aluminium, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium and calcium content in bone of end-stage renal failure patients. Clin Chem 45:1548-1556, 1999
3. SCHROOTEN I, ELSEVIERS MM, LAMBERTS LV, et al. Increased serum strontium levels in dialysis patients. An epidemiological survey. Kidney Int 56:1886-1892, 1999
4. SCHROOTEN I, CABRERA WE, DAUWE S, et al: Strontium causes osteomalacia in chronic renal failure rats. Kidney Int 54:448-456, 1998
5. CABRERA WE, SCHROOTEN I, DE BROE ME, D'HAESE PC: Review: Strontium and bone. J Bone Miner Res 14:661-668, 1999
6. SHORR E, CARTER AC: The value of strontium as an adjuvant to calcium in the mineralization of the skeleton in osteoporosis in man. Bull Hosp Joint Dis 13:59-66, 1952
7. MCCASLIN F, JANES JM: The effect of strontium lactate on the treatment of osteoporosis. Proc Staff Meet Mayo Clin 34:329-334, 1959
8. MARIE JP, GARBA MT, HOTT M, MIRAVET L: Effect of low doses of stable strontium on bone metabolism in rats. Miner Electrol Metab 11:5-13, 1985
9. GRYNPAS M, MARIE JP: Effects of low doses of strontium on bone quality and quantity in rats. Bone 11:313-319, 1990
10. MARIE JP, HOTT M, MODROWSKI D, et al: An uncoupling agent containing strontium prevents bone loss, depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Min Res 8:607-615, 1993
11. MATSUMOTO A: Effect of strontium on the epiphyseal cartilage plate of rat tibiae-histological and radiographic studies. Jpn J Pharmacol 26:675-681, 1976
12. OMDAHL JL, DELUCA HF: Rachitogenic activity of dietary strontium Inhibition of intestinal calcium absorption and 1,25 dihydroxycholecalciferol synthesis. J Biol Chem 247:5520-5526, 1972
13. 3 metabolism strontium and the involvement of parathyroid hormone. Arch Biochem Biophys 184:172-178, 1977
14. MATTAR AG, SIEGEL BA: Bone tracers: Radionuclide imaging and related techniques, in Skeletal research: An Experimental Approach, edited by SIMMONS DJ, KUSRIN AS, New York, Academic Press, 1979, pp 455-486
15. JOHNSON A: The influence of strontium on characteristic factors of bone. Calcif Tissue Res 11:215-221, 1973
16. EISENBERG E: The biological metabolism of strontium, in Biological Mineralization, edited by ZIPKIN I, New York, John Wiley & Sons, 1973, pp 435-442
17. QUARLES LD, GITELMAN HJ, DREZNER MK: Induction of de novo bone formation in the beagle: a novel effect of aluminum. J Clin Invest 81:1056-1066, 1988
18. 3. Kidney Int 31:736-743, 1987
19. QUARLES LD: Paradoxical toxic and trophic osseous actions of aluminum: potential explanations. Min Electrolyte Metab 17:233-239, 1991
20. MARIE PJ, AMMANN P, BOIVIN G, REY C: Mechanism of action and therapeutic potential of strontium in bone. Calcif Tissue Int 169:121-129, 2001
21. GRYNPAS MD, HAMILTON E, CHEUNG R, et al: Strontium increases vertebral bone volume in at a low dose that does not induce detectable mineralization defect. Bone 18:253-259, 1996
22. HENROTIN Y, LABASSE A, ZHENG SX, et al: Strontium ranelate increases cartilage matrix formation. J Bone Miner Res 16(2):299-308, 2001
23. OMDAHL JL, DELUCA HF: Strontium induced rickets: Metabolic basis. Science 174:949-951, 1971
24. 3-induced calcium binding protein (Ca-BP) and calcium absorption in chick intestine. Proc Soc Exp Biol Med 133:960-963, 1970
25. D'HAESE PC, VAN LANDEGHEM GF, LAMBERTS LV, et al: Measurement of strontium in serum, urine, bone and soft tissues by Zeeman atomic absorption spectrometry. Clin Chem 43:121-128, 1997
26. PARFITT AM: Bone histomorphometry: proposed system for standardization of nomenclature, symbols and units. Calcif Tissue Int 42:284-286, 1988
27. COHEN-SOLAL ME, AUGRY F, MAURAS Y, et al: Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients. Nephrol Dial Transplant 17:449-454, 2002
28. GOODMAN WG: Short-term aluminum administration in the rat: Reductions in bone formation without osteomalacia. J Lab Clin Med 103:749-757, 1984
29. GOODMAN WG, GILLIGAN J, HORST R: Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia. J Clin Inv 73:171-181, 1984
30. BOVER J, RODRIGUEZ M, TRINIDAD P, et al: Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat. Kidney Int 45(4):953-961, 1994
31. SMANS KA, D'HAESE PC, VAN LANDEGHEM GF, et al: Transferrin-mediated uptake of aluminum by human parathyroid gland cells result in hypoparathyroidism. Nephrol Dial Transplant 15:1328-1336, 2000
32. ELSEVIERS MM, VERPOOTEN GA, DE BROE ME, DE BACKER GG. Interpretation of creatinine clearance [letter]. Lancet 1(8530):457, 1987